Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

NCT00495053 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment and financial issues

Conditions

Overactive Bladder

Interventions

DRUG: hMaxi-K
OTHER: Placebo

Sponsor

Urovant Sciences GmbH

Collaborators

[object Object]